Skip to main content

Table 2 Logistic regression analysis of factors associated with advanced stage at diagnosis, NSW Cancer Registry 2000–2008

From: After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales

 

Distant

  

Distant/regional

  
 

Unadjusted

Model 1

Model 2

Unadjusted

Model 1

Model 2

 

OR (95% CI)

AOR (95% CI)a

AOR (95% CI)b

OR (95% CI)

AOR (95% CI)a

AOR (95% CI)b

Aboriginal status

 Non-Aboriginal

1

1

1

1

1

1

 Aboriginal

1.46 (1.33–1.61)

1.59 (1.45–1.75)

1.30 (1.17–1.44)

1.46 (1.34–1.58)

1.47 (1.36–1.60)

1.29 (1.18–1.40)

Sex

 Female

1

1

1

1

1

1

 Male

0.91 (0.89–0.93)

0.88 (0.86–0.90)

0.91 (0.89–0.93)

0.66 (0.65–0.67)

0.65 (0.64–0.66)

0.96 (0.94–0.98)

Residential remoteness

 Major cities

1

1

1

1

1

1

 Inner regional

0.94 (0.92–0.96)

0.87 (0.85–0.89)

0.91 (0.88–0.94)

0.92 (0.90–0.93)

0.89 (0.87–0.90)

0.92 (0.90–0.94)

 Outer regional

1.00 (0.97–1.04)

0.90 (0.86–0.93)

0.94 (0.89–0.98)

0.96 (0.94–0.99)

0.91 (0.88–0.94)

0.95 (0.92–0.98)

 Remote/ Very remote

1.19 (1.05–1.36)

1.02 (0.89–1.16)

0.97 (0.84–1.12)

1.09 (0.98–1.20)

0.98 (0.88–1.09)

0.97 (0.87–1.09)

SEIFA quintile

 1 (least disadvantaged)

1

1

1

1

1

1

 2

1.17 (1.13–1.21)

1.21 (1.17–1.25)

1.10 (1.06–1.14)

1.07 (1.04–1.10)

1.10 (1.07–1.12)

1.02 (0.99–1.05)

 3

1.17 (1.14–1.21)

1.22 (1.18–1.26)

1.07 (1.03–1.11)

1.05 (1.03–1.08)

1.10 (1.07–1.12)

1.00 (0.97–1.03)

 4

1.17 (1.13–1.21)

1.23 (1.19–1.27)

1.07 (1.03–1.11)

1.05 (1.02–1.07)

1.11 (1.08–1.13)

1.01 (0.98–1.03)

 5 (most disadvantaged)

1.32 (1.28–1.36)

1.40 (1.35–1.45)

1.17 (1.13–1.22)

1.15 (1.12–1.18)

1.21 (1.18–1.24)

1.05 (1.02–1.08)

  1. AOR adjusted odds ratio, CI confidence interval, OR odds ratio, SEIFA socio-economic index for areas (Index of relative socio-economic disadvantage was used in this study).
  2. aModel 1 adjusted for age, sex, year of diagnosis, remoteness and SEIFA.
  3. bModel 2 further adjusted for cancer site.